CN Patent

CN110267645A — 用于治疗干眼病的眼用组合物

Assigned to Novaliq GmbH · Expires 2019-09-20 · 7y expired

What this patent protects

本发明提供用于局部治疗干眼病的药物组合物，其包含溶解在1‑全氟丁基‑戊烷中的约0.05至0.1％(w/v)的环孢菌素，并提供其给药和治疗方法。本发明还提供了包含此类组合物的试剂盒。

USPTO Abstract

本发明提供用于局部治疗干眼病的药物组合物，其包含溶解在1‑全氟丁基‑戊烷中的约0.05至0.1％(w/v)的环孢菌素，并提供其给药和治疗方法。本发明还提供了包含此类组合物的试剂盒。

Drugs covered by this patent

Patent Metadata

Patent number
CN110267645A
Jurisdiction
CN
Classification
—
Expires
2019-09-20
Drug substance claim
No
Drug product claim
No
Assignee
Novaliq GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.